Resistance to paclitaxel is associated with a variant of the gene BCL2 in multiple tumor types

Paclitaxel, the most commonly used form of chemotherapy, is utilized in curative protocols in different types of cancer. The response to treatment differs among patients. Biological interpretation of a mechanism to explain this personalized response is still unavailable. Since paclitaxel is known to...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:NPJ Precis Oncol
Main Authors: Ben-Hamo, Rotem, Zilberberg, Alona, Cohen, Helit, Bahar-Shany, Keren, Wachtel, Chaim, Korach, Jacob, Aviel-Ronen, Sarit, Barshack, Iris, Barash, Danny, Levanon, Keren, Efroni, Sol
Formato: Artigo
Idioma:Inglês
Publicado: Nature Publishing Group UK 2019
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6478919/
https://ncbi.nlm.nih.gov/pubmed/31044156
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41698-019-0084-3
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares